Favier Guillaume, Gladman Dafna D, Merola Joseph F, Armstrong April W, Boehncke Wolf Henning, Helliwell Philip S
From the Strategy Group, Healthcare and Life Sciences, KPMG LLP ( UK), London; University of Leeds, Leeds; Bradford Hospitals UK National Health Service (NHS) Foundation Trust, Bradford, UK; University of Toronto; Krembil Research Institute; Psoriatic Disease Program, Toronto Western Hospital, Toronto, Ontario, Canada; Department of Dermatology and Medicine, Division of Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; University of Southern California, Los Angeles, California, USA; Division of Dermatology, Geneva University Hospital; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.
G. Favier, PhD, Manager, Strategy Group, Healthcare and Life Sciences, KPMG LLP ( UK); D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto, and Senior Scientist, Krembil Research Institute, and Director, Psoriatic Disease Program, Toronto Western Hospital; J.F. Merola, MD, MMSc, Assistant Professor, Department of Dermatology and Medicine, Division of Rheumatology, Brigham and Women's Hospital, Harvard Medical School; A.W. Armstrong, MD, University of Southern California; W.H. Boehncke, MD, Division of Dermatology, Geneva University Hospital, and Department of Pathology and Immunology, University of Geneva; P.S. Helliwell, DM, PhD, FRCP, University of Leeds, and Bradford Hospitals NHS Foundation Trust.
J Rheumatol. 2017 May;44(5):674-678. doi: 10.3899/jrheum.170142.
Members of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), in partnership with KPMG LLP (UK), conducted interviews at selected research centers around the globe to analyze the process of care in psoriasis and psoriatic arthritis (PsA): pre-diagnosis, referral and diagnosis, treatment, and followup. Ten major challenges emerged, many of which were universally recognized across centers; the top 4 included limited awareness of PsA among non-rheumatologists, a disparate approach to care, late referral and diagnosis, and an inadequate management of comorbidities.
银屑病和银屑病关节炎研究与评估小组（GRAPPA）与毕马威会计师事务所（英国）合作，在全球选定的研究中心进行了访谈，以分析银屑病和银屑病关节炎（PsA）的护理过程：诊断前、转诊与诊断、治疗及随访。出现了十大主要挑战，其中许多在各中心普遍存在；前四大挑战包括非风湿病科医生对PsA的认识有限、护理方法不一、转诊和诊断延迟以及合并症管理不足。
